Novel macrolide antibiotics and preparation thereof
AssigneeToyo Jozo Kabushiki Kaisha
InventorsMasaru Otani, Shuzo Satoi, Naoki Muto, Tetsu Saito, Tadashiro Fujii, Seiji Katsumata, Mitsuo Hayashi, Masaru Ono
Life of this patent
Estimating the term…
Loading patent…
AssigneeToyo Jozo Kabushiki Kaisha
InventorsMasaru Otani, Shuzo Satoi, Naoki Muto, Tetsu Saito, Tadashiro Fujii, Seiji Katsumata, Mitsuo Hayashi, Masaru Ono
Estimating the term…
A novel microorganism species belonging to the genus Micromonospora, i.e. Micromonospora sp. A 11725 is found to be capable of producing novel macrolide antibiotics A 11725 I, A 11725 II and A 11725 III. Novel antibiotics A 11725 Ia and A 11725 IIa are also found to be derived by chemical modification of the antibiotics A 11725 I and A 11725 II, respectively. All of these antibiotics or salts thereof exhibit excellent antibacterial and anti-mycoplasmal activities against various microorganisms such as Staphylococcus or Mycoplasma, and therefore useful for various purposes including medicaments.
A novel antibiotic substance A 11725 I or a pharmaceutically acceptable salt thereof having the following properties:
A novel antibiotic substance A 11725 II or a pharmaceutically acceptable salt thereof having the following properties:
A novel antibiotic substance A 11725 III or a pharmaceutically acceptable salt thereof having the following properties:
A novel antibiotic substance A 11725 Ia or a pharmaceutically acceptable salt thereof having the following properties:
A novel antibiotic substance A 11725 IIa or a pharmaceutically acceptable salt thereof having the following properties:
A process for producing antibiotic substances, which comprises culturing Micromonospora sp. A 11725 (NRRL 11452) which is capable of producing at least one of the antibiotic substances A 11725 I, II and III in a medium containing an assimilatable carbon source, a nitrogen source and an inorganic substance under aerobic conditions to accumulate said antibiotic substances in said medium and then collecting and isolating the accumulated antibiotic substances by separation from the cultured product, said antibiotic substance A 11725 I having the following properties:
A process for producing antibiotic substances, which comprises culturing Micromonospora sp. A 11725 (NRRL 11452) in a culture medium containing an assimilatable carbon source, a nitrogen source and an inorganic substance under aerobic conditions to produce and to accumulate at least one antibiotic substance A 11725 I and A 11725 II within said medium, then isolating the thus-accumulated at least one antibiotic substance by separation from the culture medium and thereafter reacting either the antibiotic substance A 11725 I or the antibiotic substance A 11725 II with a chemical reagent which can convert epoxy groups in the molecule of said substance to double bonds to produce either an antibiotic substance A 11725 Ia or an antibiotic substance A 11725 Ia, respectively, said antibiotic substance A 11725 Ia having the following properties:
A pure culture of microorganism strain Micromonospora sp. A 11725 (NRRL 11452) which has been isolated from the soil and which is capable of producing at least one of the antibiotic substances A 11725 I, II and III upon being cultured in a nutrient medium.
Dependencies are inferred from the claim text.